Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Heart Closure Devices Market’s Growth Trajectory From 2025 To 2034?

The market size for heart closure devices has experienced swift expansion in the recent past. The market value is projected to rise from $2.77 billion in 2024, to $3.08 billion in 2025, representing a compound annual growth rate (CAGR) of 11.2%. Factors contributing to the growth during the historic period include enhanced awareness among healthcare practitioners, rising numbers of device approvals from regulatory bodies, more favorable reimbursement policies, a surge in cardiovascular diseases, and an increasing elderly population.

The market size for heart closure devices is projected to experience significant expansion in the forthcoming years, reaching a value of $4.86 billion by 2029, progressing at a compound annual growth rate (CAGR) of 12.0%. This expansion during the forecast period can be attributed to several factors including an upsurge in congenital heart defects, an increase in the use of MRI procedures, a rise in the occurrence of heart strokes and atrial fibrillation, as well as an increased inclination towards minimally invasive methods. Key trends expected to dominate the forecast period range from the incorporation of multi-functional devices and technological advancements, to material and design innovations, the merging of imaging technologies, and the development of bioresorbable materials.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20828&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Heart Closure Devices Market?

The escalating prevalence of cardiovascular diseases (CVDs) is anticipated to boost advancement in the heart closure devices market. Factors such as ageing, unhealthy lifestyle habits, genetics, and the expanding occurrence of risk components like hypertension, diabetes, and obesity are escalating the prevalence of cardiovascular diseases (CVDs). Heart closure devices work to decrease the likelihood of issues stemming from congenital heart defects by performing minimally invasive procedures to seal irregular gaps in the heart, enhancing blood circulation and averting additional health complications. For instance, in 2024, as per data from the non-profit Singapore Heart Foundation, the total fatalities related to cardiovascular disease reached 26,885, scaled up from the previous year’s numbers. Notably, deaths due to ischemic heart disease rose from 5,290 in 2022 to 5,302 in 2023. As such, the growing prevalence of cardiovascular diseases (CVDs) is fuelling the expansion of the heart closure devices market.

Which Primary Segments of the Heart Closure Devices Market Are Driving Growth and Industry Transformations?

The heart closure devicesmarket covered in this report is segmented –

1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery

4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices

2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices

4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices

5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20828&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Heart Closure Devices Market?# Market?

North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Heart Closure Devices Market?

As part of their strategic approach, key players in the heart closure devices market are investing in the creation of innovative and technologically superior solutions including patent foramen ovale occlusion systems. These systems play a crucial role in medical procedures by closing a continuous opening in the heart, known as a patent foramen ovale, which is usually closed naturally after birth but in some cases remains open. A clear example of this approach was seen in September 2022 when Abbott Laboratories, a leading medical devices company in the US, introduced their Amplatzer Talisman PFO Occlusion System. This advanced device has been devised specifically for treating patients with PFO, especially those at an increased risk of stroke recurrence. The main attributes of the system are a pre-fixed occluder for more organized procedures, a versatile 30mm size enhancing adaptability, and a recapturable design, all of which work collectively to ensure an efficient PFO closure and minimize the chances of future strokes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report

What Parameters Are Used to Define the Heart Closure Devices Market?

Heart closure devices are advanced medical tools designed to seal holes or openings in the heart, commonly arising from congenital defects or surgical interventions. They are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart abnormalities. These minimally invasive devices are typically delivered through catheter-based procedures, offering a safer alternative to open-heart surgery.?

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20828

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model